Evidence map›Paper›PMID 22684455›Full record

ArticleCancer discovery2012

miR-23a, a critical regulator of "migR"ation and metastasis in colorectal cancer.

Zhiwei Wang, Wenyi Wei, Fazlul H Sarkar

Open access · bronzeAbstract readComment
In one paragraph

Article in Cancer discovery, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  19. Clinical value of microRNA-23a upregulation in non-small cell lung cancer.International journal of clinical and experimental medicine · 2015
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zhiwei WangDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Wenyi Wei
Fazlul H Sarkar
Wayne State University · USThe Barbara Ann Karmanos Cancer Institute · US

Funding

Interplay between Cdh1 and major regulatory pathways in human cancerR01GM089763 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WEI, WENYI · 2009 to 2018
$3.0M
Novel Targets of Indoles in Prostate CancerR01CA108535 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2004 to 2014
$2.7M
Molecular Mechanism of Genistein (Isoflavone) in Prostate CancerR01CA083695 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2001 to 2011
$2.3M
RO1: A novel and targeted approach to inhibit invasion and angiogenesisR01CA131151 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2008 to 2012
$1.8M
Prevention of Tumor Progression by a Novel ApproachR01CA154321 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2011 to 2015
$1.5M
FoxM1: A molecular target in pancreatic cancerR01CA132794 · NCI · WAYNE STATE UNIVERSITY · PI SARKAR, FAZLUL H. · 2009 to 2013
$1.5M
Functional analysis of beta-TRCP in cell cycle control and DNA damage responseR01GM094777 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WEI, WENYI · 2012 to 2015
$1.3M
NCI NIH HHS 1R01CA132794NCI NIH HHS 1R01CA154321NCI NIH HHS 5R01CA131151NCI NIH HHS R01 CA083695NCI NIH HHS R01 CA108535NCI NIH HHS R01 CA131151NCI NIH HHS R01 CA132794NCI NIH HHS R01 CA154321NIGMS NIH HHS GM089763NIGMS NIH HHS GM094777NIGMS NIH HHS R01 GM089763NIGMS NIH HHS R01 GM094777
6 · The paper itself

Abstract

Jahid and colleagues have shown that miR-23a promotes the transition from indolent to invasive colorectal cancer through inhibition of the MTSS1 tumor suppressor. This study reveals a novel role of miR-23a in the acceleration of colorectal cancer progression.

Indexed as

AdenocarcinomaAdenomaAnimalsColorectal NeoplasmsHumansMicroRNAsMicroRNAsMirn23b microRNA, mouse

Identifiers

PMID22684455
PMCPMC3375870
OpenAlexW2154671690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.